Add time:09/02/2019         Source:sciencedirect.com

Over half of the active pharmaceutical ingredients currently approved within the US are pharmaceutical salts. Selection of suitable pharmaceutical salts is carried out during late research or early development phase. Therefore several properties of different pharmaceutical salts of a new chemical entity are assessed during salt screening and salt selection. This typically includes physico-chemical behavior, dissolution rate and pharmacokinetics of a pharmaceutical salt. Beyond these properties also toxicological aspects have to be taken into account. As a starting point for a toxicological assessment we present an overview of the usage of pharmaceutical salts as described in the FDA’s Orange Book including maximum daily doses for the most important administration routes.

We also recommend Trading Suppliers and Manufacturers of ETHYLENEDIAMINETETRAACETIC ACID DICALCIUM SALT (cas 19709-85-4). Pls Click Website Link as below: cas 19709-85-4 suppliers